Skip to content

AstraZeneca

Active
Public limited companyfounded 194877 yrs activeAlfons Gossetlaan 40, 1702 Dilbeek, BelgiumKBO/BCE: BE 0400.165.679
Summary

AstraZeneca has been active since 1948 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €46.9m and a net result of €8.6m. Equity is growing by ~7.7% per year across the filed fiscal years. Its solvency ranks better than 49% of 4926 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability64=
Solvency69▲+1
Growth82▲+12
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,000,000 at 30 days acceptable
Liquidity ample (current ratio 1.75 against 1.77 in 2024; short-term debt: 55.5% and cash: 1.4% of total assets), but 55.5% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 77 years 0 80 y
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
44.5%
Return on assets
8.2%
Age of the figures
9 mo
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-06-2026, 44 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
44 d early
2024
38 d early
2023
14 d early
2022
40 d early
2021
37 d early
2020
46 d early
2019
on the day
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 31 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 28 November 1948, AstraZeneca was incorporated.1 BIOTHERA was merged into the company in 2009.2 In 2018 the registered office moved to Groot-Bijgaarden.3 Of the 5 current board members, Paul Van Mullem has served longest, since 2019.4 Revenue went from EUR 117 million in 2018 to EUR 351 million in 2025 and headcount from 167 to 234 full-time equivalents.5

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 30-07-2009
  3. 3Belgian State Gazette, 31-05-2018
  4. 4Belgian State Gazette, 13-07-2022
  5. 5National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
€351.2m▲ 10.6%
2024 · €317.5m
EBIT margin
3.4%▲ 0.6pp
2024 · 2.8%
Net result
€8.6m▲ 5.6%
2024 · €8.2m
Working capital
€44.1m▲ 15.5%
2024 · €38.2m
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Turnover€172.2m▲ 6.5%€226.1m▲ 31.3%€278.7m▲ 23.2%€317.5m▲ 13.9%€351.2m▲ 10.6%
Operating result€5.8m▲ 29.3%€7.5m▲ 27.9%€10.3m▲ 37.6%€8.8m▼ 14.1%€12.0m▲ 35.6%
Net result€3.9mabove the sector's middle half▲ 29.9%€5.2mabove the sector's middle half▲ 33.8%€9.1mabove the sector's middle half▲ 75.0%€8.2mabove the sector's middle half▼ 10.1%€8.6mabove the sector's middle half▲ 5.6%
EBIT margin3.4%▲ 0.6pp3.3%▼ 0.1pp3.7%▲ 0.4pp2.8%▼ 0.9pp3.4%▲ 0.6pp
Equity€48.7mabove the sector's middle half▲ 8.7%€53.9mabove the sector's middle half▲ 10.7%€63.0mabove the sector's middle half▲ 16.9%€38.2mabove the sector's middle half▼ 39.4%€46.9mabove the sector's middle half▲ 22.6%
Total assets€90.6mabove the sector's middle half▲ 24.3%€99.6mabove the sector's middle half▲ 10.0%€94.1mabove the sector's middle half▼ 5.5%€88.0mabove the sector's middle half▼ 6.5%€105.4mabove the sector's middle half▲ 19.7%
Debt€41.8m▲ 52.1%€45.7m▲ 9.3%€31.1m▼ 31.9%€49.8m▲ 60.3%€58.5m▲ 17.4%
Working capital€48.6m▲ 7.9%€57.9m▲ 19.3%€62.9m▲ 8.6%€38.2m▼ 39.4%€44.1m▲ 15.5%
Solvency53.8%within the sector's middle half▼ 7.7pp54.2%within the sector's middle half▲ 0.3pp67.0%above the sector's middle half▲ 12.8pp43.4%within the sector's middle half▼ 23.6pp44.5%within the sector's middle half▲ 1.1pp
Staff (FTE)179.6above the sector's middle half▲ 5.0%187.2above the sector's middle half▲ 4.2%211.5above the sector's middle half▲ 13.0%221.7above the sector's middle half▲ 4.8%234.4above the sector's middle half▲ 5.7%
above within below the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
€0€5.0m€10.0mOperating result 2021: €5.8m€5.8mNet result 2021: €3.9m€3.9mOperating result 2022: €7.5m€7.5mNet result 2022: €5.2m€5.2mOperating result 2023: €10.3m€10.3mNet result 2023: €9.1m€9.1mOperating result 2024: €8.8m€8.8mNet result 2024: €8.2m€8.2mOperating result 2025: €12.0m€12.0mNet result 2025: €8.6m€8.6m20212022202320242025€0€5m€10mOperating result 2023: €10.3m€10mNet result 2023: €9.1m€9.1mOperating result 2024: €8.8m€8.8mNet result 2024: €8.2m€8.2mOperating result 2025: €12.0m€12mNet result 2025: €8.6m€8.6m202320242025
The operating result recovers in 2025; 2025 is 36% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €105.4m
Fixed assets €2.8m ▲ 3,520%
Current assets €102.6m ▲ 16.6%
Equity and liabilities €105.4m
Equity €46.9m ▲ 22.6%
Provisions €0 =
Debt €58.5m ▲ 17.4%
Debt's share of the balance-sheet total falls from 56.6% to 55.5%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€12.1m▲
2024 · €8.9m
Cash flow
€8.8m▲
2024 · €8.2m
Current ratio
1.75▼
2024 · 1.77
Debt to equity
1.25▼
2024 · 1.30
ROE
18.4%▼
2024 · 21.4%
ROA
8.2%▼
2024 · 9.3%
Interest coverage
26.97▲
2024 · 20.01
Debt ≤ 1 year
€58.5m▲
2024 · €49.8m
Income taxes
€3.2m▲
2024 · €2.9m
Staff costs
€43.7m▲
2024 · €39.6m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 1,552 companies that looked in July 2024 the way this one looks now, 0.1% went bankrupt within 24 months and 97% are still going.

  • Medium-sized
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.1% went bankrupt
3.2% stopped otherwise
97% still going

For this company itself Checked computes a bankruptcy probability of 0.3% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 1,552 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 70 lines
Balance sheet Code20242025
Assets
Total assets20/58€88.0m€105.4m▲
Fixed assets21/28€78,063€2.8m▲
Tangible fixed assets22/27€78,063€2.8m▲
Plant, machinery and equipment23€0€1.0m▲
Furniture and vehicles24€46,023€63,865▲
Other tangible fixed assets26€32,041€176,586▲
Assets under construction and advance payments27-€1.6m
Current assets29/58€88.0m€102.6m▲
Stocks and contracts in progress3€0€0=
Amounts receivable within one year40/41€86.2m€100.4m▲
Trade receivables40€49.2m€53.6m▲
Other amounts receivable41€37.0m€46.8m▲
Cash at bank and in hand54/58€752,524€1.5m▲
Deferred charges and accrued income490/1€1.0m€657,674▼
Equity and liabilities
Total equity and liabilities10/49€88.0m€105.4m▲
Equity10/15€38.2m€46.9m▲
Contributions10/11€26.6m€26.6m=
Capital10€22.0m€22.0m=
Issued capital100€22.0m€22.0m=
Outside capital11€4.6m€4.6m=
Share premium1100/10€4.6m€4.6m=
Reserves13€2.8m€2.8m=
Non-distributable reserves130/1€2.2m€2.2m=
Legal reserve130€2.2m€2.2m=
Other1319€32,276€32,276=
Tax-exempt reserves132€556,226€556,226=
Profit (loss) carried forward14€8.9m€17.5m▲
Provisions and deferred taxes16€0€0=
Provisions for liabilities and charges160/5€0€0=
Pensions and similar obligations160€0€0=
Amounts payable17/49€49.8m€58.5m▲
Amounts payable within one year42/48€49.8m€58.5m▲
Trade debts44€38.5m€47.4m▲
Suppliers440/4€38.5m€47.4m▲
Taxes, remuneration and social security45€11.3m€11.1m▼
Taxes450/3€2.2m€2.4m▲
Remuneration and social security454/9€9.1m€8.7m▼
Other amounts payable47/48€0-
Income statement Code20242025
Operating income70/76A€338.8m€375.9m▲
Turnover70€317.5m€351.2m▲
Other operating income74€21.1m€24.7m▲
Non-recurring operating income76A€164,893€0▼
Operating charges60/66A€329.9m€363.9m▲
Goods for resale, raw materials and consumables60€132.6m€137.5m▲
Purchases600/8€132.6m€137.5m▲
Services and other goods61€31.5m€39.0m▲
Remuneration, social security and pensions62€39.6m€43.7m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€24,345€149,184▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€0-
Other operating charges640/8€126.2m€143.6m▲
Non-recurring operating charges66A€33€0▼
Operating profit (loss)9901€8.8m€12.0m▲
Financial income75/76B€3.0m€650,186▼
Recurring financial income75€3.0m€650,186▼
Income from current assets751€3.0m€634,283▼
Other financial income752/9€6,652€15,904▲
Financial charges65/66B€719,492€750,893▲
Recurring financial charges65€719,492€750,893▲
Debt charges650€443,008€449,913▲
Other financial charges652/9€276,484€300,980▲
Profit (loss) for the period before taxes9903€11.1m€11.9m▲
Income taxes67/77€2.9m€3.2m▲
Taxes670/3€2.9m€3.2m▲
Profit (loss) for the period9904€8.2m€8.6m▲
Profit (loss) for the period to be appropriated9905€8.2m€8.6m▲
Appropriation of the result
Profit (loss) to be appropriated9906€41.9m€17.5m▼
Profit (loss) brought forward from the previous period14P€33.7m€8.9m▼
Profit to be distributed694/7€33.0m€0▼
Return on contributions (dividend)694€33.0m€0▼
Social balance
Average headcount (FTE)9087221.7234.4▲

The notes to these accounts (62 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Operating income70/76A€211.2m€246.9m€304.8m€338.8m€375.9m▲ 11.0%
Turnover70€172.2m€226.1m€278.7m€317.5m€351.2m▲ 10.6%
Other operating income74€38.9m€20.8m€26.1m€21.1m€24.7m▲ 16.8%
Non-recurring operating income76A---€164,893€0▼ 100%
Operating charges60/66A€205.3m€239.4m€294.5m€329.9m€363.9m▲ 10.3%
Goods for resale, raw materials and consumables60€102.1m€106.2m€120.2m€132.6m€137.5m▲ 3.7%
Purchases600/8€102.1m€106.2m€120.2m€132.6m€137.5m▲ 3.7%
Services and other goods61€22.5m€26.3m€32.6m€31.5m€39.0m▲ 23.8%
Remuneration, social security and pensions62€30.4m€34.7m€38.4m€39.6m€43.7m▲ 10.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€128,317€60,519€29,864€24,345€149,184▲ 513%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4--€123,046€0--
Provisions for liabilities and charges: additions (uses and reversals)635/8-€489,622-----
Other operating charges640/8€50.6m€72.1m€103.2m€126.2m€143.6m▲ 13.8%
Non-recurring operating charges66A€264-€12,459€33€0▼ 100%
Operating profit (loss)9901€5.8m€7.5m€10.3m€8.8m€12.0m▲ 35.6%
Financial income75/76B€26,838€271,647€2.9m€3.0m€650,186▼ 78.4%
Recurring financial income75€26,838€271,647€2.9m€3.0m€650,186▼ 78.4%
Income from current assets751€5,049€250,772€2.8m€3.0m€634,283▼ 78.9%
Other financial income752/9€21,788€20,875€2,299€6,652€15,904▲ 139%
Financial charges65/66B€295,819€315,114€495,545€719,492€750,893▲ 4.4%
Recurring financial charges65€295,819€315,114€495,545€719,492€750,893▲ 4.4%
Debt charges650€125,288€139,469€261,529€443,008€449,913▲ 1.6%
Other financial charges652/9€170,531€175,645€234,016€276,484€300,980▲ 8.9%
Profit (loss) for the period before taxes9903€5.6m€7.4m€12.6m€11.1m€11.9m▲ 6.7%
Income taxes67/77€1.7m€2.2m€3.5m€2.9m€3.2m▲ 9.9%
Taxes670/3€1.7m€2.2m€3.5m€2.9m€3.2m▲ 9.9%
Profit (loss) for the period9904€3.9m€5.2m€9.1m€8.2m€8.6m▲ 5.6%
Profit (loss) for the period to be appropriated9905€3.9m€5.2m€9.1m€8.2m€8.6m▲ 5.6%
Line20212022202320242025Change
Assets
Total assets20/58€90.6m€99.6m€94.1m€88.0m€105.4m▲ 19.7%
Fixed assets21/28€209,184€144,765€102,442€78,063€2.8m▲ 3,520%
Intangible fixed assets21€1,217-----
Tangible fixed assets22/27€204,067€144,765€102,442€78,063€2.8m▲ 3,520%
Plant, machinery and equipment23€32,651€2,550€196€0€1.0m-
Furniture and vehicles24€109,124€90,007€60,121€46,023€63,865▲ 38.8%
Other tangible fixed assets26€62,292€52,208€42,124€32,041€176,586▲ 451%
Assets under construction and advance payments27----€1.6m-
Financial fixed assets28€3,900-----
Other financial fixed assets284/8€3,900-----
Amounts receivable and cash guarantees285/8€3,900-----
Current assets29/58€90.3m€99.4m€94.0m€88.0m€102.6m▲ 16.6%
Stocks and contracts in progress3--€0€0€0-
Amounts receivable within one year40/41€89.2m€97.4m€91.9m€86.2m€100.4m▲ 16.5%
Trade receivables40€52.1m€35.4m€43.5m€49.2m€53.6m▲ 8.9%
Other amounts receivable41€37.1m€62.0m€48.4m€37.0m€46.8m▲ 26.7%
Cash at bank and in hand54/58€1.1m€1.3m€1.0m€752,524€1.5m▲ 96.1%
Deferred charges and accrued income490/1€447€798,424€1.1m€1.0m€657,674▼ 36.9%
Equity and liabilities
Total equity and liabilities10/49€90.6m€99.6m€94.1m€88.0m€105.4m▲ 19.7%
Equity10/15€48.7m€53.9m€63.0m€38.2m€46.9m▲ 22.6%
Contributions10/11€26.6m€26.6m€26.6m€26.6m€26.6m=
Capital10€22.0m€22.0m€22.0m€22.0m€22.0m=
Issued capital100€22.0m€22.0m€22.0m€22.0m€22.0m=
Outside capital11€4.6m€4.6m€4.6m€4.6m€4.6m=
Share premium1100/10€4.6m€4.6m€4.6m€4.6m€4.6m=
Reserves13€2.8m€2.8m€2.8m€2.8m€2.8m=
Non-distributable reserves130/1€2.2m€2.2m€2.2m€2.2m€2.2m=
Legal reserve130€2.2m€2.2m€2.2m€2.2m€2.2m=
Other1319€32,276€32,276€32,276€32,276€32,276=
Tax-exempt reserves132€556,226€556,226€556,226€556,226€556,226=
Profit (loss) carried forward14€19.4m€24.6m€33.7m€8.9m€17.5m▲ 97.6%
Provisions and deferred taxes16€42,232-€0€0€0=
Provisions for liabilities and charges160/5€42,232-€0€0€0=
Pensions and similar obligations160€42,232-€0€0€0=
Amounts payable17/49€41.8m€45.7m€31.1m€49.8m€58.5m▲ 17.4%
Amounts payable within one year42/48€41.8m€41.5m€31.1m€49.8m€58.5m▲ 17.4%
Financial debts43-€323,886€0---
Credit institutions430/8-€323,886€0---
Trade debts44€26.6m€20.4m€18.8m€38.5m€47.4m▲ 23.1%
Suppliers440/4€26.6m€20.4m€18.8m€38.5m€47.4m▲ 23.1%
Taxes, remuneration and social security45€15.2m€20.8m€11.8m€11.3m€11.1m▼ 1.7%
Taxes450/3€8.6m€12.1m€2.1m€2.2m€2.4m▲ 10.6%
Remuneration and social security454/9€6.6m€8.8m€9.7m€9.1m€8.7m▼ 4.6%
Other amounts payable47/48--€454,145€0--
Accrued charges and deferred income492/3€12,865€4.1m€0---
Line20212022202320242025Change
Profit (loss) for the period9904€3.9m€5.2m€9.1m€8.2m€8.6m▲ 5.6%
+ Depreciation and write-downs630€128,317€60,519€29,864€24,345€149,184▲ 513%
Operating cash flow (approximation)€4.0m€5.3m€9.1m€8.2m€8.8m▲ 7.1%
Investment in fixed assets (approximation)-€3,900€12,459€33-€2.9m▼ 8,693,645%
Change in cash-€112,568-€238,720-€267,680€723,392▲ 370%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
17-06
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
23-06
NBB filing Annual accounts filed
fiscal year 2024 · full schema
04-04
State Gazette act Appointment: Angela Thompson (director)
Mandate compensation5 facts ▸
  • General meeting, 21/02/2025
  • Board meeting, 25/02/2025
  • Director appointment, Angela Thompson (director)
  • Director appointment, Angela Thompson (managing director)
  • Mandate compensation, Angela Thompson
2024
05-08
State Gazette act Resignation: Keira Driansky (director)
3 facts ▸
  • Board meeting, 15/05/2024
  • Director resignation, Keira Driansky (director)
  • Director resignation, Keira Driansky (day-to-day manager)
17-07
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial Highest result since 2018net €9.1m ▲75%
Net result €9.1m, the highest in the series.
05-07
State Gazette act Appointment: PwC Bedrijfsrevisoren BV (statutory auditor)
Permanent representative: Romain Seffer3 facts ▸
  • General meeting, 26/05/2023
  • Auditor appointment, PwC Bedrijfsrevisoren BV (statutory auditor)
  • Permanent representative, Romain Seffer (vertegenwoordiger belast met de uitoefening van het mandaat)
21-06
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial Equity above €50mEq €53.9m ▲10.7%
5 profitable years in a row build equity to €53.9m.
13-10
State Gazette act Resignation: Anne-Laure Dréno (director)
Appointment: Keira Driansky (director) · Mandate compensation7 facts ▸
  • General meeting, 21/09/2022
  • Board meeting, 21/09/2022
  • Director resignation, Anne-Laure Dréno (director)
  • Director appointment, Keira Driansky (director)
  • Mandate compensation, Keira Driansky
  • Director resignation, Anne-Laure Dréno (day-to-day manager)
  • Director appointment, Keira Driansky (day-to-day manager)
13-07
State Gazette act Reappointments: Anne-Laure Dréno, Jennifer Olivero and 2 others
Mandate compensation · Power of attorney10 facts ▸
  • General meeting, 19/05/2022
  • Director reappointment, Anne-Laure Dréno (director)
  • Director reappointment, Jennifer Olivero (director)
  • Director reappointment, Luca Taliercio (director)
  • Director reappointment, Paul Van Mullem (director)
  • Mandate compensation, Anne-Laure Dréno
  • Mandate compensation, Jennifer Olivero
  • Mandate compensation, Luca Taliercio
  • Mandate compensation, Paul Van Mullem
  • Power of attorney, NautaDutilh BV
24-06
NBB filing Annual accounts filed
fiscal year 2021 · full schema
Show earlier events
07-04
State Gazette act Appointments: Jennifer Olivero (director) and Luca Taliercio (director)
Resignation: Nathalie Demeere (director) · Mandate compensation · Director discharge8 facts ▸
  • General meeting, 16/03/2022
  • Director appointment, Jennifer Olivero (director)
  • Director resignation, Nathalie Demeere
  • Mandate compensation, Jennifer Olivero
  • Director appointment, Luca Taliercio (director)
  • Mandate compensation, Luca Taliercio
  • Director discharge, Luca Taliercio
  • Power of attorney, NautaDutilh BV
2021
03-11
State Gazette act Statutes amendment
Capital3 facts ▸
  • General meeting, 04-10-2021
  • Statutes amendment
  • Capital, €22.000.000
19-10
State Gazette act Resignation: Nathalie Demeere (director)
Appointment: Jennifer Olivero (director) · Mandate compensation4 facts ▸
  • Board meeting, 29/09/2021
  • Director resignation, Nathalie Demeere (director)
  • Director appointment, Jennifer Olivero (director)
  • Mandate compensation, Jennifer Olivero
15-06
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial Weakest financial yearnet €3.0m ▼2.6%
Net result drops to €3.0m, the lowest in the series; recovery starts the following year.
31-07
NBB filing Annual accounts filed
fiscal year 2019 · full schema
24-06
State Gazette act Appointment: BV PwC Bedrijfsrevisoren (statutory auditor)
Permanent representative: Romain Seffer2 facts ▸
  • Auditor appointment, BV PwC Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Romain Seffer (representative)
2019
05-12
State Gazette act Resignation: Lieve Wollaert (director)
Appointment: Nathalie Demeere (director) · Power of attorney4 facts ▸
  • General meeting, 30/10/2019
  • Director resignation, Lieve Wollaert (director)
  • Director appointment, Nathalie Demeere (director)
  • Power of attorney, NautaDutilh BVBA
11-07
NBB filing Annual accounts filed
fiscal year 2018 · full schema
17-06
State Gazette act Resignations: Hervé Dussart (managing director) and Valerie Buyse (director)
Appointments: Anne-Laure Dreno (day-to-day manager) and Paul Van Mullem (director) · Mandate compensation · Power of attorney12 facts ▸
  • Board meeting, 09/05/2019
  • General meeting, 29/05/2019
  • Director resignation, Hervé Dussart (managing director)
  • Director resignation, Hervé Dussart (director)
  • Director resignation, Valerie Buyse (director)
  • Director appointment, Anne-Laure Dreno (day-to-day manager)
  • Director appointment, Paul Van Mullem (director)
  • Director appointment, Anne-Laure Dreno (director)
  • Mandate compensation, Paul Van Mullem
  • Mandate compensation, Anne-Laure Dreno
  • Power of attorney, NautaDutilh BVBA
  • Board composition, e5, e3, e6
2018
25-10
State Gazette act Resignation: Leen Hofkens (director)
Appointment: Lieve Wollaert (director) · Mandate compensation4 facts ▸
  • General meeting, 28/09/2018
  • Director resignation, Leen Hofkens (director)
  • Director appointment, Lieve Wollaert (director)
  • Mandate compensation, Lieve Wollaert
05-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
31-05
State Gazette act Registered office
Registered-office move · Establishment unit change3 facts ▸
  • Board meeting, 07/05/2018
  • Registered-office move, Alfons Gossetlaan 40 bus 201, 1702 Groot-Bijgaarden
  • Establishment unit change, Alfons Gossetlaan 40 bus 201, 1702 Groot-Bijgaarden
2017
26-06
NBB filing Annual accounts filed
fiscal year 2016 · full schema
16-06
State Gazette act Appointments: KPMG Bedrijfsrevisoren BV CVBA (statutory auditor) and PricewaterhouseCoopers Bedrijfsrevisoren CVBA (statutory auditor)
Permanent representatives: Raf Cox and Romain Seffer · Resignation: KPMG Bedrijfsrevisoren BV CVBA (statutory auditor)6 facts ▸
  • General meeting, 24/05/2017
  • Auditor appointment, KPMG Bedrijfsrevisoren BV CVBA (statutory auditor)
  • Permanent representative, Raf Cox
  • Director resignation, KPMG Bedrijfsrevisoren BV CVBA (statutory auditor)
  • Auditor appointment, PricewaterhouseCoopers Bedrijfsrevisoren CVBA (statutory auditor)
  • Permanent representative, Romain Seffer
2016
04-10
State Gazette act Reappointments: Leen Hofkens, Valerie Buyse and Hervé Dussart
Appointment: KPMG Bedrijfsrevisoren BV CVBA (statutory auditor) · Permanent representative: Raf Cox · Mandate compensation10 facts ▸
  • General meeting, 27/05/2016
  • Director reappointment, Leen Hofkens (director)
  • Director reappointment, Valerie Buyse (director)
  • Director reappointment, Hervé Dussart (director)
  • Mandate compensation, Leen Hofkens
  • Mandate compensation, Valerie Buyse
  • Mandate compensation, Hervé Dussart
  • Auditor appointment, KPMG Bedrijfsrevisoren BV CVBA (statutory auditor)
  • Permanent representative, Raf Cox
  • Power of attorney, NautaDutilh
29-04
State Gazette act Resignation: Philippe Buée (managing director)
Appointment: Hervé Dussart (managing director) · Power of attorney7 facts ▸
  • Board meeting, 14/03/2016
  • General meeting, 18/03/2016
  • Director resignation, Philippe Buée (managing director)
  • Director appointment, Hervé Dussart (managing director)
  • Director resignation, Philippe Buée (director)
  • Director appointment, Hervé Dussart (director)
  • Power of attorney, Anne Tilleux
11-04
State Gazette act Resignation: Philippe Bué (managing director)
Appointment: Hervé Dussart (managing director)6 facts ▸
  • Board meeting, 14/03/2016
  • General meeting, 18/03/2016
  • Director resignation, Philippe Bué (managing director)
  • Director appointment, Hervé Dussart (managing director)
  • Director resignation, Philippe Bué (director)
  • Director appointment, Hervé Dussart (director)
2015
20-11
State Gazette act Permanent representatives: Filip DE BOCK and Raf COX
Resignation: Filip DE BOCK (permanent representative) · Appointment: Raf COX (permanent representative)5 facts ▸
  • Board meeting, 27/10/2015
  • Permanent representative, Filip DE BOCK
  • Director resignation, Filip DE BOCK (permanent representative)
  • Permanent representative, Raf COX
  • Director appointment, Raf COX (permanent representative)
18-06
State Gazette act Appointment: Valerie Buyse (director)
Mandate compensation · Power of attorney4 facts ▸
  • Board meeting, 01/06/2015
  • Director appointment, Valerie Buyse (director)
  • Mandate compensation, Valerie Buyse
  • Power of attorney, Anne Tilleux
08-04
State Gazette act Appointment: Philippe Buée (day-to-day manager)
2 facts ▸
  • Board meeting, 17/03/2015
  • Director appointment, Philippe Buée (day-to-day manager)
04-03
State Gazette act Resignations: Christiane Wijsen (director) and Tarja Stenvall (director)
Appointment: Philippe Buée (director) · Mandate compensation · Power of attorney9 facts ▸
  • General meeting, 04/02/2015
  • Director resignation, Christiane Wijsen (director)
  • Director appointment, Philippe Buée (director)
  • Mandate compensation, Philippe Buée
  • Director resignation, Tarja Stenvall (director)
  • Power of attorney, Anne Tilleux
  • Number of directors, 2
  • Correction, einddatum mandaat bestuurders Leen Hofkens, Tarja Stenvall en Chris Wijsen
  • Correction, 22/09/2014, 14173235
2014
03-11
State Gazette act Resignation: Tarja Stenvall (director)
Power of attorney6 facts ▸
  • General meeting, 14/10/2014
  • Board meeting, 14/10/2014
  • Director resignation, Tarja Stenvall (director)
  • Director resignation, Tarja Stenvall (managing director)
  • Power of attorney, Anne Tilleux
  • Board composition, 2
22-09
State Gazette act Resignation: Stéphane Gaullier (director)
Appointment: Chris Wijsen (director) · Mandate compensation · Power of attorney6 facts ▸
  • General meeting
  • Director resignation, Stéphane Gaullier (director)
  • Director appointment, Chris Wijsen (director)
  • Mandate compensation, Chris Wijsen
  • Board composition, Confirmation of number of directors and their names
  • Power of attorney, Anne Tilleux
2013
06-09
State Gazette act Resignation: Piet Schutyser (director)
Reappointments: Leen Hofkens, Tarja Stenvall and Piet Schutyser · Appointments: KPMG Bedrijfsrevisoren BV CVBA (statutory auditor) and Stéphane Gaullier (director) · Permanent representative: Filip de Bock18 facts ▸
  • General meeting, 31-05-2013
  • Director resignation, Piet Schutyser (director)
  • Director reappointment, Leen Hofkens (director)
  • Director reappointment, Tarja Stenvall (director)
  • Mandate compensation, Leen Hofkens
  • Mandate compensation, Tarja Stenvall
  • Director reappointment, Piet Schutyser (director)
  • Mandate compensation, Piet Schutyser
  • Statutes amendment
  • Statutes amendment
  • Auditor appointment, KPMG Bedrijfsrevisoren BV CVBA (statutory auditor)
  • Permanent representative, Filip de Bock
  • +6 further facts in this act
31-07
State Gazette act Resignation: Piet Schutyser (director)
Appointment: Stéphane Gaullier (director) · Mandate compensation · Power of attorney5 facts ▸
  • General meeting, 30/06/2013
  • Director resignation, Piet Schutyser (director)
  • Director appointment, Stéphane Gaullier (director)
  • Mandate compensation, Stéphane Gaullier
  • Power of attorney, Anne Tilleux
2012
13-11
State Gazette act Resignation: Geoff Miller (director)
Appointment: Leen Hofkens (director) · Mandate compensation4 facts ▸
  • Board meeting, 10/10/2012
  • Director resignation, Geoff Miller (director)
  • Director appointment, Leen Hofkens (director)
  • Mandate compensation, Leen Hofkens
13-11
State Gazette act Appointments: Leen Hofkens (director) and Tarja Stenvall (director)
Resignations: Geoff Miller (director) and Joris Silon (director) · Mandate compensation7 facts ▸
  • General meeting, 17/10/2012
  • Director appointment, Leen Hofkens (director)
  • Director resignation, Geoff Miller (director)
  • Mandate compensation, Leen Hofkens
  • Director resignation, Joris Silon (director)
  • Director appointment, Tarja Stenvall (director)
  • Mandate compensation, Tarja Stenvall
13-11
State Gazette act Resignation: Joris Silon (director)
Appointment: Tarja Stenvall (managing director) · Power of attorney · Mandate compensation6 facts ▸
  • Board meeting, 23/10/2012
  • Director resignation, Joris Silon (director)
  • Director resignation, Joris Silon (managing director)
  • Power of attorney, Joris Silon
  • Director appointment, Tarja Stenvall (managing director)
  • Mandate compensation, Tarja Stenvall
2011
10-08
State Gazette act Appointment: Joris Silon (director)
Resignation: Françoise Bartoli (director) · Mandate compensation4 facts ▸
  • General meeting, 27/05/2011
  • Director appointment, Joris Silon (director)
  • Director resignation, Françoise Bartoli (director)
  • Mandate compensation, Joris Silon
2010
04-11
State Gazette act Resignation: Françoise Bartoli (director)
Appointment: Joris Silon (director) · Power of attorney · Mandate compensation8 facts ▸
  • Board meeting, 16/09/2010
  • Director resignation, Françoise Bartoli (director)
  • Director appointment, Joris Silon (director)
  • Director resignation, Françoise Bartoli (managing director)
  • Power of attorney, Françoise Bartoli
  • Director appointment, Joris Silon (managing director)
  • Mandate compensation, Joris Silon
  • Power of attorney, Françoise Bartoli
23-06
State Gazette act Reappointments: Françoise Bartoli, Geoff Miller and Piet Schutyser
Appointment: Klynveld, Peat Marwick, Goerdeler, Bedrijfsrevisoren (statutory auditor) · Permanent representative: Filip De Bock · Mandate compensation9 facts ▸
  • General meeting, 28-05-2010
  • Director reappointment, Françoise Bartoli (director)
  • Director reappointment, Geoff Miller (director)
  • Director reappointment, Piet Schutyser (director)
  • Mandate compensation, Françoise Bartoli
  • Mandate compensation, Geoff Miller
  • Mandate compensation, Piet Schutyser
  • Auditor appointment, Klynveld, Peat Marwick, Goerdeler, Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Filip De Bock
2009
07-12
State Gazette act Resignation: Béatrice Ronfié-Nadaud (director)
Appointment: Geoff Milier (director) · Mandate compensation4 facts ▸
  • General meeting, 19/10/2009
  • Director resignation, Béatrice Ronfié-Nadaud (director)
  • Director appointment, Geoff Milier (director)
  • Mandate compensation, Geoff Milier
30-07
State Gazette act Capital & shares · Restructuring
Merger · Accounting effect · Power of attorney5 facts ▸
  • General meeting, 01/07/2009
  • Merger, verrichting gelijkgesteld met een fusie door overneming
  • Accounting effect, 01/01/2009
  • Power of attorney, Leslie Van den Branden
  • Power of attorney, Leslie Van den Branden
29-07
State Gazette act Appointment: Luk Vranken (director)
Mandate compensation3 facts ▸
  • General meeting, 29/05/2009
  • Director appointment, Luk Vranken (director)
  • Mandate compensation, Luk Vranken
2006
12-07
State Gazette act Appointments: Françoise Bartoli (director) and Béatrice Ronflé-Nadaud (director)
Resignations: James Ward-Lilley (director) and Pierre Callebaut (director)5 facts ▸
  • General meeting, 29/05/2006
  • Director appointment, Françoise Bartoli (director)
  • Director resignation, James Ward-Lilley (director)
  • Director appointment, Béatrice Ronflé-Nadaud (director)
  • Director resignation, Pierre Callebaut (director)
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
35 of 36 acts read
About the unread acts

Of the 36 Belgian State Gazette acts we know for this company, 35 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
5 directors, 2 in day-to-day management, last change in 2025

Board 5

Paul Van Mullem
Director · since 01-06-2019
Current
Jennifer Olivero
Director · since 29-09-2021
Current
Luca Taliercio
Director · since 07-04-2022
Current
Angela Thompson
Director · since 21-02-2025
Current
Current
5 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
Béatrice Ronflé-Nadaud
Director · since 29-05-2006
Not recently confirmed
Luk Vranken
Director · since 01-07-2009
Not recently confirmed
Geoff Milier
Director · since 16-09-2009
Not recently confirmed
Chris Wijsen
Director · since 01-09-2014
Not recently confirmed
Not recently confirmed

Day-to-day management 2

Angela Thompson
Managing director · since 25-02-2025
Current
Keira Driansky
Day-to-day manager
Current

Permanent representatives 1

Raf Cox
Permanent representative · since 31-12-2015
Not recently confirmed

Statutory auditor 1

BV PwC Bedrijfsrevisoren
Statutory auditor · since 16-06-2017 · perm. rep.: Romain Seffer
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
1 of this company's 36 Belgian State Gazette acts has not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Dilbeek · 3 establishment units since 2000
seat establishment 1 of 3 establishment units on the map
Ground area
4,478 m²
Building footprint
1,360 m²
Volume, LiDAR
22,164 m³
Parcel 23026A0149/00M000, Flanders · tallest building 20.8 m, ±6 floors. Linked by address, not a title deed.
26 companies at this address See who is registered here
3 establishment units
Alfons Gossetlaan 40, 1702 Dilbeek
NACE 3310202
since 20002.039.738.071
Rue André Dumont 5, 1435 Mont-Saint-Guibert
Other research and development on natural sciences
since 20252.386.236.721
Rue André Dumont 9, 1435 Mont-Saint-Guibert
Other research and development on natural sciences
since 20252.387.219.488
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23026A0149/00M000 Flanders 4,477 m² 1 · 1,360 m² 20.8 m · 6 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

32 people since 2006, 12 in office
Show
  • Board
  • Day-to-day management
  • Permanent representative
  • Statutory auditor
  • not recently confirmed
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
Paul Van Mullem
  • Director, from 01-06-2019 to date
Jennifer Olivero
  • Director, from 29-09-2021 to date
Luca Taliercio
  • Director, from 07-04-2022 to date
Keira Driansky
  • Director, from 21-09-2022 to 30-04-2024
  • Director, from 21-09-2022 to date
  • Day-to-day manager, from 21-09-2022 to 30-04-2024
  • Day-to-day manager, from 21-09-2022 to date
Angela Thompson
  • Director, from 21-02-2025 to date
  • Managing director, from 25-02-2025 to date
BV PwC Bedrijfsrevisoren
  • Statutory auditor, from 16-06-2017 to date
Béatrice Ronflé-Nadaud
  • Director, from 29-05-2006 not ended, last confirmed 12-07-2006
Luk Vranken
  • Director, from 01-07-2009 not ended, last confirmed 29-07-2009
Geoff Milier
  • Director, from 16-09-2009 not ended, last confirmed 07-12-2009
Stéphane Gaullier
  • Director, from 30-06-2013 to 01-09-2014
  • Director, from 30-06-2013 not ended, last confirmed 06-09-2013
Chris Wijsen
  • Director, from 01-09-2014 not ended, last confirmed 22-09-2014
Raf Cox
  • Permanent representative, from 31-12-2015 not ended, last confirmed 20-11-2015
Anne-Laure Dreno
  • Director, from 01-06-2019 to 21-09-2022
  • Day-to-day manager, from 01-06-2019 to 21-09-2022
Nathalie Demeere
  • Director, from 01-11-2019 to 03-09-2021
  • Board, until 07-04-2022
Lieve Wollaert
  • Director, from 28-09-2018 to 01-11-2019
Hervé Dussart
  • Director, from 05-11-2015 to 01-06-2019
  • Managing director, from 05-11-2015 to 01-06-2019
Valerie Buyse
  • Director, from 01-06-2015 to 01-06-2019
Leen Hofkens
  • Director, from 10-10-2012 to 28-09-2018
KPMG BEDRIJFSREVISOREN BV CVBA
  • Statutory auditor, from 31-05-2013 to 16-06-2017
FILIP DE BOCK
  • Permanent representative, until 31-12-2015
Philippe Bué
  • Director, until 05-11-2015
  • Managing director, until 05-11-2015
Philippe Buée
  • Director, from 05-01-2015 to 05-11-2015
  • Day-to-day manager, from 08-04-2015 to 05-11-2015
Christiane Wijsen
  • Director, until 05-01-2015
Tarja Stenvall
  • Director, from 15-10-2012 to 01-10-2014
  • Managing director, from 23-10-2012 to 01-10-2014
  • Director, until 01-10-2014
Piet Schutyser
  • Director, already before 23-06-2010 to 30-06-2013
Klynveld Peat Marwick Goerdeler Bedrijfsrevisoren
  • Statutory auditor, from 28-05-2010 to 31-05-2013
Geoff Miller
  • Director, already before 23-06-2010 to 28-09-2012
  • Director, until 13-11-2012
Joris Silon
  • Director, from 15-09-2010 to 12-10-2012
  • Managing director, from 15-09-2010 to 12-10-2012
  • Director, until 12-10-2012
Françoise Bartoli
  • Director, from 29-05-2006 to 15-09-2010
  • Managing director, until 15-09-2010
  • Director, until 10-08-2011
Béatrice Ronfié-Nadaud
  • Director, until 01-09-2009
James Ward-Lilley
  • Director, until 12-07-2006
Pierre Callebaut
  • Director, until 12-07-2006
See the board, name and seat on a given date →

Articles of association

Who signs
Purpose
In België en in het buitenland, ofwel voor zichzelf ofwel voor rekening van derden, alle verrichtingen in verband met de productie, de fabricage, de bereiding, de voorbereiding, de…
Full purpose

In België en in het buitenland, ofwel voor zichzelf ofwel voor rekening van derden, alle verrichtingen in verband met de productie, de fabricage, de bereiding, de voorbereiding, de verpakking, het opslaan, het transport, de distributie, de invoer en de uitvoer van, de verlening van diensten met betrekking tot, de exploitatie door de concessie van vergunningen of anderszins, en in het algemeen de handel in: 1. geneesmiddelen en andere farmaceutische producten, alsook geneeskundige en chirurgische instrumenten en apparaten van paramedische aard, tandheelkundig materieel, veterinaire producten, parfumerie en gezondheidsproducten; 2. alle artikels, apparaten, producten en alle andere voorwerpen nodig of nuttig voor de fabricage, de productie of de voorbereiding van de hoger vermelde producten en apparaten, alsook onderdelen ervan; 3. alle materialen, producten, artikels, apparaten, machines of alle andere voorwerpen welke kunnen aangewend worden voor of in verband staan met de hogervermelde producten, diensten en activiteiten. De vennootschap mag zich eveneens inlaten met het beheer van andere vennootschappen en aan deze allerhande diensten verstrekken. Zij zal ook alle financiële verrichtingen mogen doen (met inbegrip van de uitgifte van al dan niet converteerbare obligaties), en alle verrichtingen van industriële, commerciële, roerende en onroerende aard welke rechtstreeks of onrechtstreeks verband houden met haar voorwerp of welk de ontwikkeling van de vennootschap en van de aangesloten vennootschappen kunnen begunstigen, en namelijk zonder dat de navolgende opsomming beperkend zou zijn, alle onroerende goederen en handelsfondsen vervreemden en verwerven, in huur nemen of verhuren, alle octrooien, vergunningen, fabrieks- of handelsmerken verkrijgen en concessies geven of afstaan. Bovendien zal zij een belang mogen nemen, bij wijze van inbreng, cessie, inschrijving, deelneming, fusie, vereniging of op elke andere manier, in elke andere onderneming, zelfs indien deze een gelijkaardig of verschillend voorwerp heeft.

Structure & network

Connections & network

5 connected companies

Ownership & control

1 board mandate
Board mandates of this companythis company sits on their board1

Acquisitions and mergers

1 transaction
Took over:BIOTHERA
operation treated as a merger by absorption · State Gazette act of 30-07-2009

Capital and shareholders

Capital over the years
  1. 03-11-2021 Capital stated in the act · 22,000,000 EUR · 44,000 shares

Public money · subsidies and aid

Flemish government

2024 to 2025 · 2 entries · 3,834 EUR awarded · 3,834 EUR paid
Year Entries awardedpaid
2025 1 1,789 EUR1,789 EUR
2024 1 2,045 EUR2,045 EUR
Schemes
2 entries · 3,834 EUR · 3,834 EUR paid · Departement Werk en Sociale Economie

Similar companies · same sector, comparable size

Of 1,903 companies in sector 46460 we hold annual accounts for 1,117. 187 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded28-11-1948
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
E-invoicing
Reachable via Peppol
Peppol ID 0208:0400165679
Registered 30-12-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.